Filing Details
- Accession Number:
- 0001566028-13-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-01 12:41:17
- Reporting Period:
- 2013-09-30
- Filing Date:
- 2013-10-01
- Accepted Time:
- 2013-10-01 12:41:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887497 | Hi Tech Pharmacal Co Inc | HITK | Pharmaceutical Preparations (2834) | 112638720 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1463267 | M Gary April | C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701 | President, Hcp Division | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-09-30 | 3,125 | $32.59 | 3,125 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-09-30 | 3,125 | $43.08 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-09-30 | 3,125 | $0.00 | 3,125 | $32.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,375 | 2013-07-16 | 2022-07-16 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.07 to $43.09, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote [1] of this Form 4.
- Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 2009 Stock Option Plan, which is a 16b-3 Plan.
- The option becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- Other than the option to acquire 9,375 shares reflected on this form as still held by Mr. April following the reported transaction, Mr. April is also the holder of additional options to acquire 18,125 shares of Hi-Tech common stock (for total options to acquire 27,500 shares still held by Mr. April), which options were granted on various dates, with various exercise prices, exercise dates, and expiration dates.